Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Biol Chem ; 285(31): 23925-35, 2010 Jul 30.
Article in English | MEDLINE | ID: mdl-20516063

ABSTRACT

The transition from latent to lytic phases of the Epstein-Barr virus life cycle is triggered by expression of a viral transactivator, BZLF1, that then induces expression of the viral immediate-early and early genes. The BZLF1 protein is post-translationally modified by a small ubiquitin-related modifier-1 (SUMO-1). Here we found that BZLF1 is conjugated at lysine 12 not only by SUMO-1 but also by SUMO-2 and 3. The K12R mutant of BZLF1, which no longer becomes sumoylated, exhibits stronger transactivation than the wild-type BZLF1 in a reporter assay system as well as in the context of virus genome with nucleosomal structures. Furthermore, exogenous supply of a SUMO-specific protease, SENP, caused de-sumoylation of BZLF1 and enhanced BZLF1-mediated transactivation. Immunoprecipitation experiments proved that histone deacetylase 3 preferentially associated with the sumoylated form of BZLF1. Levels of the sumoylated BZLF1 increased as lytic replication progressed. Based on these observations, we conclude that sumoylation of BZLF1 regulates its transcriptional activity through histone modification during Epstein-Barr virus productive replication.


Subject(s)
Herpesvirus 4, Human/metabolism , Histone Deacetylases/metabolism , SUMO-1 Protein/metabolism , Trans-Activators/metabolism , Transcription, Genetic , Cell Line , Cell Line, Tumor , Humans , Models, Genetic , Mutation , Promoter Regions, Genetic , Protein Processing, Post-Translational , Stomach Neoplasms/metabolism , Transcriptional Activation , Viral Proteins/genetics
2.
Virology ; 389(1-2): 75-81, 2009 Jun 20.
Article in English | MEDLINE | ID: mdl-19427010

ABSTRACT

The Epstein-Barr virus (EBV) BGLF4 gene product is the only protein kinase encoded by the virus genome. In order to elucidate its physiological roles in viral productive replication, we here established a BGLF4-knockout mutant and a revertant virus. While the levels of viral DNA replication of the deficient mutant were equivalent to those of the wild-type and the revertant, virus production was significantly impaired. Expression of the BGLF4 protein in trans fully complemented the low yield of the mutant virus, while expression of a kinase-dead (K102I) form of the protein failed to restore the virus titer. These results demonstrate that BGLF4 plays a significant role in production of infectious viruses and that the kinase activity is crucial.


Subject(s)
Epstein-Barr Virus Infections/virology , Herpesvirus 4, Human/enzymology , Protein Serine-Threonine Kinases/metabolism , Viral Proteins/metabolism , Virus Replication , Cell Line , DNA Replication , DNA, Viral/biosynthesis , Gene Knockout Techniques , Genetic Complementation Test , Genome, Viral , Herpesvirus 4, Human/genetics , Herpesvirus 4, Human/physiology , Humans , Protein Serine-Threonine Kinases/genetics , Viral Proteins/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...